By Chad Terhune LOS ANGELES (Reuters) -Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last ...

Gov. Jeff Landry struck language from the Louisiana budget plan that could have provided state employees and public school teachers with insurance coverage for popular weight-loss medication over the ...

Recent analysis of U.S. pharmacy claims reveals nearly two-thirds of patients who began weight-loss drugs Wegovy or Zepbound last year continued usage for a full year, up from previous years. Improved ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.

Wegovy and Ozempic are costly and have been driving up Medi-Cal spending. The governor's office says scaling back coverage for these drugs would save the state up to $680 million by 2029.

Insurance companies should not drag their feet. They must take meaningful steps to ensure that obesity treatment is easily ...

Using the WeGoTogether savings offer from Novo Nordisk, the manufacturer of Wegovy, people with health insurance coverage may pay as little as $0 per 28-day supply of Wegovy, and people paying out ...

As Ohio cuts off state employees' coverage of medications for weight loss, a lawmaker who has benefited from the drugs wants to bring them back.

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year ...